摘要
目的:探讨施他宁在急性坏死性胰腺炎治疗中的作用。方法:1995年8月至1996年9月本院消化科共收治急性坏死性胰腺炎27例,其中24例用施他宁治疗,3例转外科手术治疗。结果:用施他宁保守治疗的24例患者中除2例死亡外均存活,存活率92％,转外科手术3例中2例死亡。结论:施他宁不失为一个治疗急性坏死性胰腺炎的良药,能大大地提高患者的存活率。
Background/Aims: To study the effection of somatostatin in treating acute necrotizing pancreatitis. Methods: 27 patients with acute necrotizing pancreatitis were observed from August 1995 to September 1996. 24 of them were treaded by somatostatin, 3 of them underwent operation. Results: The surviving rate of treatment by somatostatin in acute necrotizing pancreatitis is 92% except 2 patients dead. Two of the three operative patients were dead. Conclusion: Somatostatin is a useful and effective drug for acute necrotizing pancreatitis and greatly enhancing the surviving rate.
出处
《胃肠病学》
1998年第1期18-19,共2页
Chinese Journal of Gastroenterology
关键词
施他宁
急性坏死性胰腺炎
治疗
Somatostatin Acute necrotizing pancreatitis Therapy
